DaVita Inc. (0I7E.L)
USD 150.4
(2.83%)
USD 150.4
(2.83%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 143.1 Million USD | 31.14% |
| 2022 | 109.12 Million USD | 1.58% |
| 2021 | 107.42 Million USD | -3.76% |
| 2020 | 111.62 Million USD | 13.96% |
| 2019 | 97.94 Million USD | -8.78% |
| 2018 | 107.38 Million USD | -40.93% |
| 2017 | 181.79 Million USD | 10.28% |
| 2016 | 164.85 Million USD | -11.16% |
| 2015 | 185.57 Million USD | 36.37% |
| 2014 | 136.08 Million USD | 53.24% |
| 2013 | 88.8 Million USD | 13.67% |
| 2012 | 78.12 Million USD | 3.16% |
| 2011 | 75.73 Million USD | -0.36% |
| 2010 | 76 Million USD | 8.52% |
| 2009 | 70.04 Million USD | -16.79% |
| 2008 | 84.17 Million USD | 4.99% |
| 2007 | 80.17 Million USD | -10.04% |
| 2006 | 89.11 Million USD | 28.92% |
| 2005 | 69.13 Million USD | 117.1% |
| 2004 | 31.84 Million USD | -3.07% |
| 2003 | 32.85 Million USD | -5.94% |
| 2002 | 34.92 Million USD | 0.08% |
| 2001 | 34.9 Million USD | 69.09% |
| 2000 | 20.64 Million USD | -37.29% |
| 1999 | 32.91 Million USD | 40.07% |
| 1998 | 23.5 Million USD | 170.11% |
| 1997 | 8.7 Million USD | 45.0% |
| 1996 | 6 Million USD | 140.0% |
| 1995 | 2.5 Million USD | 47.06% |
| 1994 | 1.7 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 126.76 Million USD | -13.06% |
| 2024 Q3 | 128.99 Million USD | 1.76% |
| 2024 Q1 | 145.8 Million USD | 1.89% |
| 2023 Q4 | 143.1 Million USD | 30.55% |
| 2023 FY | 143.1 Million USD | 31.14% |
| 2023 Q2 | 110.29 Million USD | 3.31% |
| 2023 Q1 | 106.77 Million USD | -2.16% |
| 2023 Q3 | 109.62 Million USD | -0.62% |
| 2022 Q3 | 106.84 Million USD | -2.44% |
| 2022 Q4 | 109.12 Million USD | 2.13% |
| 2022 FY | 109.12 Million USD | 1.58% |
| 2022 Q1 | 107.72 Million USD | 0.27% |
| 2022 Q2 | 109.52 Million USD | 1.67% |
| 2021 Q4 | 107.42 Million USD | -5.84% |
| 2021 FY | 107.42 Million USD | -3.76% |
| 2021 Q1 | 116.32 Million USD | 4.21% |
| 2021 Q2 | 115.36 Million USD | -0.82% |
| 2021 Q3 | 114.09 Million USD | -1.1% |
| 2020 Q2 | 97.9 Million USD | 2.32% |
| 2020 Q1 | 95.68 Million USD | -2.31% |
| 2020 Q3 | 106.25 Million USD | 8.53% |
| 2020 Q4 | 111.62 Million USD | 5.05% |
| 2020 FY | 111.62 Million USD | 13.96% |
| 2019 Q2 | 96.81 Million USD | -7.12% |
| 2019 Q1 | 104.23 Million USD | -2.93% |
| 2019 Q3 | 98.64 Million USD | 1.88% |
| 2019 Q4 | 97.94 Million USD | -0.7% |
| 2019 FY | 97.94 Million USD | -8.78% |
| 2018 Q1 | 125.55 Million USD | -30.94% |
| 2018 FY | 107.38 Million USD | -40.93% |
| 2018 Q4 | 107.38 Million USD | 17.87% |
| 2018 Q3 | 91.1 Million USD | -19.18% |
| 2018 Q2 | 112.72 Million USD | -10.22% |
| 2017 Q4 | 181.79 Million USD | 17.73% |
| 2017 FY | 181.79 Million USD | 10.28% |
| 2017 Q1 | 174.15 Million USD | 5.64% |
| 2017 Q2 | 199.3 Million USD | 14.44% |
| 2017 Q3 | 154.42 Million USD | -22.52% |
| 2016 FY | 164.85 Million USD | -11.16% |
| 2016 Q4 | 164.85 Million USD | -17.8% |
| 2016 Q3 | 200.56 Million USD | 1.61% |
| 2016 Q2 | 197.38 Million USD | 2.44% |
| 2016 Q1 | 192.68 Million USD | 3.83% |
| 2015 FY | 185.57 Million USD | 36.37% |
| 2015 Q1 | 145.74 Million USD | 7.09% |
| 2015 Q3 | 173.05 Million USD | 8.6% |
| 2015 Q4 | 185.57 Million USD | 7.24% |
| 2015 Q2 | 159.35 Million USD | 9.34% |
| 2014 Q3 | 114.67 Million USD | 15.08% |
| 2014 FY | 136.08 Million USD | 53.24% |
| 2014 Q2 | 99.65 Million USD | -1.51% |
| 2014 Q1 | 101.17 Million USD | 13.93% |
| 2014 Q4 | 136.08 Million USD | 18.67% |
| 2013 Q2 | 77.99 Million USD | 1.85% |
| 2013 Q4 | 88.8 Million USD | 4.6% |
| 2013 FY | 88.8 Million USD | 13.67% |
| 2013 Q3 | 84.89 Million USD | 8.85% |
| 2013 Q1 | 76.58 Million USD | -1.98% |
| 2012 Q3 | 78.32 Million USD | 0.82% |
| 2012 Q1 | 72.28 Million USD | -4.55% |
| 2012 FY | 78.12 Million USD | 3.16% |
| 2012 Q4 | 78.12 Million USD | -0.25% |
| 2012 Q2 | 77.68 Million USD | 7.47% |
| 2011 FY | 75.73 Million USD | -0.36% |
| 2011 Q4 | 75.73 Million USD | 3.33% |
| 2011 Q3 | 73.29 Million USD | 6.8% |
| 2011 Q2 | 68.62 Million USD | -1.45% |
| 2011 Q1 | 69.64 Million USD | -8.38% |
| 2010 Q2 | 69.38 Million USD | 1.98% |
| 2010 Q1 | 68.03 Million USD | -2.86% |
| 2010 Q3 | 68.95 Million USD | -0.63% |
| 2010 Q4 | 76 Million USD | 10.24% |
| 2010 FY | 76 Million USD | 8.52% |
| 2009 Q4 | 70.04 Million USD | 1.49% |
| 2009 Q1 | 71.35 Million USD | -15.23% |
| 2009 Q2 | 65.35 Million USD | -8.41% |
| 2009 Q3 | 69.01 Million USD | 5.6% |
| 2009 FY | 70.04 Million USD | -16.79% |
| 2008 FY | 84.17 Million USD | 4.99% |
| 2008 Q1 | 76.8 Million USD | -4.2% |
| 2008 Q2 | 81.22 Million USD | 5.75% |
| 2008 Q3 | 82.49 Million USD | 1.57% |
| 2008 Q4 | 84.17 Million USD | 2.04% |
| 2007 FY | 80.17 Million USD | -10.04% |
| 2007 Q4 | 80.17 Million USD | 6.03% |
| 2007 Q1 | 69.45 Million USD | -22.07% |
| 2007 Q2 | 69.86 Million USD | 0.59% |
| 2007 Q3 | 75.61 Million USD | 8.23% |
| 2006 Q4 | 89.11 Million USD | -10.29% |
| 2006 Q3 | 99.33 Million USD | 6.4% |
| 2006 Q2 | 93.36 Million USD | 5.79% |
| 2006 Q1 | 88.25 Million USD | 27.67% |
| 2006 FY | 89.11 Million USD | 28.92% |
| 2005 Q4 | 69.13 Million USD | 91.86% |
| 2005 Q3 | 36.03 Million USD | 1.56% |
| 2005 FY | 69.13 Million USD | 117.1% |
| 2005 Q2 | 35.48 Million USD | 2.26% |
| 2005 Q1 | 34.69 Million USD | 8.96% |
| 2004 Q3 | 30.66 Million USD | 8.22% |
| 2004 FY | 31.84 Million USD | -3.07% |
| 2004 Q1 | 26.18 Million USD | -20.29% |
| 2004 Q4 | 31.84 Million USD | 3.84% |
| 2004 Q2 | 28.33 Million USD | 8.21% |
| 2003 FY | 32.85 Million USD | -5.94% |
| 2003 Q4 | 32.85 Million USD | 27.62% |
| 2003 Q3 | 25.74 Million USD | -14.51% |
| 2003 Q2 | 30.11 Million USD | 18.24% |
| 2003 Q1 | 25.46 Million USD | -27.09% |
| 2002 Q3 | 21.93 Million USD | -30.97% |
| 2002 Q4 | 34.92 Million USD | 59.27% |
| 2002 Q2 | 31.76 Million USD | 12.74% |
| 2002 Q1 | 28.17 Million USD | -19.26% |
| 2002 FY | 34.92 Million USD | 0.08% |
| 2001 Q4 | 34.9 Million USD | 5.21% |
| 2001 FY | 34.9 Million USD | 69.09% |
| 2001 Q3 | 33.17 Million USD | -25.63% |
| 2001 Q1 | 45.56 Million USD | 120.75% |
| 2001 Q2 | 44.6 Million USD | -2.11% |
| 2000 Q1 | 24.66 Million USD | -25.07% |
| 2000 Q3 | 37.42 Million USD | 88.4% |
| 2000 Q4 | 20.64 Million USD | -44.85% |
| 2000 Q2 | 19.86 Million USD | -19.46% |
| 2000 FY | 20.64 Million USD | -37.29% |
| 1999 Q1 | - USD | -100.0% |
| 1999 Q4 | 32.91 Million USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 FY | 32.91 Million USD | 40.07% |
| 1999 Q2 | - USD | 0.0% |
| 1998 Q4 | 23.5 Million USD | 0.0% |
| 1998 Q1 | - USD | -100.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 FY | 23.5 Million USD | 170.11% |
| 1998 Q2 | - USD | 0.0% |
| 1997 Q1 | - USD | -100.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q4 | 8.7 Million USD | 0.0% |
| 1997 FY | 8.7 Million USD | 45.0% |
| 1996 FY | 6 Million USD | 140.0% |
| 1996 Q4 | 6 Million USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1995 Q2 | 1.7 Million USD | 0.0% |
| 1995 Q3 | - USD | -100.0% |
| 1995 FY | 2.5 Million USD | 47.06% |
| 1995 Q4 | - USD | 0.0% |
| 1994 FY | 1.7 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Phreesia, Inc. | - USD | -Infinity% |
| Accuray Incorporated | 138.32 Million USD | -3.456% |
| Align Technology, Inc. | 296.9 Million USD | 51.801% |
| Elevance Health Inc. | -46.33 Billion USD | 100.309% |
| AxoGen, Inc. | 23.02 Million USD | -521.655% |
| Boston Scientific Corporation | 2.48 Billion USD | 94.239% |
| CVS Health Corporation | 18.02 Billion USD | 99.206% |
| Cardinal Health, Inc. | 14.95 Billion USD | 99.043% |
| Centene Corporation | - USD | -Infinity% |
| HCA Healthcare, Inc. | 2.02 Billion USD | 92.919% |
| Hologic, Inc. | 679.8 Million USD | 78.949% |
| Humana Inc. | - USD | -Infinity% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | 62.369% |
| Laboratory Corporation of America Holdings | 474.6 Million USD | 69.847% |
| Masimo Corporation | 545 Million USD | 73.742% |
| McKesson Corporation | 21.13 Billion USD | 99.323% |
| Patterson Companies, Inc. | 782.89 Million USD | 81.721% |
| Quest Diagnostics Incorporated | 190 Million USD | 24.682% |
| ResMed Inc. | 822.25 Million USD | 82.596% |
| Henry Schein, Inc. | 1.81 Billion USD | 92.115% |
| Teladoc Health, Inc. | 29.51 Million USD | -384.888% |
| Universal Health Services, Inc. | 216.98 Million USD | 34.049% |
| Veeva Systems Inc. | - USD | -Infinity% |
| Baxter International Inc. | 2.82 Billion USD | 94.933% |
| Becton, Dickinson and Company | 3.27 Billion USD | 95.628% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 88.276% |
| Danaher Corporation | 2.59 Billion USD | 94.483% |
| Stryker Corporation | 4.84 Billion USD | 97.045% |
| Medtronic plc | 5.21 Billion USD | 97.257% |